TABLE II.
Chelator Regiments in our Population From the Baseline (2005–2006), Mid Study (2009) and Last Assessment (2012)
| Chelators regimens | Baseline 2005–2006; n = 30a | Mid study 2009; n = 40 | Last assessment 2012b; n = 41 |
|---|---|---|---|
| DFO n (%) | 3 (10) | 4 (10) | 5 (12) |
| Exjade n (%) | 27 (90) | 29 (73) | 27 (66) |
| L1 n (%) | – | – | 3 (7) |
| DFO/L1 n (%) | – | 3 (8) | 2 (5) |
| DFO/Exjade n (%) | – | 4 (10) | 2 (5) |
| Research chelators n (%) | – | – | 2 (5) |
a
Three new patients in 2006. Sixteen patients switched DFO for Exjade between 2005 and 2006. One patient switched DFO/L1 for Exjade between 2005 and 2006.
b
Last assessment in 3 patients was in 2010 and in 2 patients in 2011.